Penile cancer is a rare malignancy which is mostly commonly found in males within the late stages of their lives. The disease is very uncommon accounting for approximately less than 30,000 cases per year globally. However, in regional areas such as Africa, South America and Asia, the rates of penile cancer can be significantly higher. With the rarity of the disease, there is a lack of awareness which could significantly impact a delayed diagnosis and therefore lead to poorer patient outcomes. A primary risk factor linked with penile cancer is the human papilloma virus (HPV) which has been associated with up to 50% of patients. Other risk factors include phimosis, poor hygiene and obesity as well as medical conditions associated with the penis.
As penile cancer is extremely rare, there are currently no trials to guide the management of the disease. However, there are advances in discussions regarding the risk of local, regional and systematic recurrence and how that may impact the quality of life for the patient. The primary treatment options include surgical resection and patients with recurring or metastatic disease, patients typically undergo systemic therapy. However, further research is required to understand how the management of penile cancer can influence patients.
This Research Topic aims to explore how penile cancer is managed and the impact it has on patients. We will also explore how research is currently aiming to improve the quality of life and survival rate for penile cancer patients. We welcome Original Research, Reviews, Systematic Reviews and Mini-Reviews.
Please note: manuscripts consisting solely of bioinformatics or computational analysis of public genomic or transcriptomic databases which are not accompanied by validation (independent cohort or biological validation in vitro or in vivo) are out of scope for this section and will not be accepted as part of this Research Topic.
Keywords:
genitourinary oncology, penile cancer, oncology, cancer, patient
Important Note:
All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
Penile cancer is a rare malignancy which is mostly commonly found in males within the late stages of their lives. The disease is very uncommon accounting for approximately less than 30,000 cases per year globally. However, in regional areas such as Africa, South America and Asia, the rates of penile cancer can be significantly higher. With the rarity of the disease, there is a lack of awareness which could significantly impact a delayed diagnosis and therefore lead to poorer patient outcomes. A primary risk factor linked with penile cancer is the human papilloma virus (HPV) which has been associated with up to 50% of patients. Other risk factors include phimosis, poor hygiene and obesity as well as medical conditions associated with the penis.
As penile cancer is extremely rare, there are currently no trials to guide the management of the disease. However, there are advances in discussions regarding the risk of local, regional and systematic recurrence and how that may impact the quality of life for the patient. The primary treatment options include surgical resection and patients with recurring or metastatic disease, patients typically undergo systemic therapy. However, further research is required to understand how the management of penile cancer can influence patients.
This Research Topic aims to explore how penile cancer is managed and the impact it has on patients. We will also explore how research is currently aiming to improve the quality of life and survival rate for penile cancer patients. We welcome Original Research, Reviews, Systematic Reviews and Mini-Reviews.
Please note: manuscripts consisting solely of bioinformatics or computational analysis of public genomic or transcriptomic databases which are not accompanied by validation (independent cohort or biological validation in vitro or in vivo) are out of scope for this section and will not be accepted as part of this Research Topic.
Keywords:
genitourinary oncology, penile cancer, oncology, cancer, patient
Important Note:
All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.